152 related articles for article (PubMed ID: 17905896)
1. Relatively decreased 11C-methionine uptake within the anaplastic component of a mixed-grade oligodendroglioma.
Miwa K; Shinoda J; Yano H; Iwama T
AJNR Am J Neuroradiol; 2007; 28(10):2005-7. PubMed ID: 17905896
[TBL] [Abstract][Full Text] [Related]
2. [11C-methionine positron emission tomography in brain tumor].
Kawai N; Kagawa M; Hatakeyama T; Tamiya T; Noshiyama Y; Yamamoto Y; Miki A; Ichikawa T
No Shinkei Geka; 2008 Oct; 36(10):847-59. PubMed ID: 18975560
[No Abstract] [Full Text] [Related]
3. Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography.
Shinozaki N; Uchino Y; Yoshikawa K; Matsutani T; Hasegawa A; Saeki N; Iwadate Y
J Neurosurg; 2011 Jun; 114(6):1640-7. PubMed ID: 21214332
[TBL] [Abstract][Full Text] [Related]
4. Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging.
Manabe O; Hattori N; Yamaguchi S; Hirata K; Kobayashi K; Terasaka S; Kobayashi H; Motegi H; Shiga T; Magota K; Oyama-Manabe N; Nishijima K; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2015 May; 42(6):896-904. PubMed ID: 25647076
[TBL] [Abstract][Full Text] [Related]
5. [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence.
Ceyssens S; Van Laere K; de Groot T; Goffin J; Bormans G; Mortelmans L
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1432-7. PubMed ID: 16908552
[TBL] [Abstract][Full Text] [Related]
6. High and low grade oligodendrogliomas (ODG): correlation of amino-acid and glucose uptakes using PET and histological classifications.
Giammarile F; Cinotti LE; Jouvet A; Ramackers JM; Saint Pierre G; Thiesse P; Jouanneau E; Guyotat J; Pelissou-Guyotat I; Setiey A; Honnorat J; Le Bars D; Frappaz D
J Neurooncol; 2004 Jul; 68(3):263-74. PubMed ID: 15332331
[TBL] [Abstract][Full Text] [Related]
7. Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation.
Roessler K; Gatterbauer B; Becherer A; Paul M; Kletter K; Prayer D; Hoeftberger R; Hainfellner J; Asenbaum S; Knosp E
Minim Invasive Neurosurg; 2007 Oct; 50(5):273-80. PubMed ID: 18058643
[TBL] [Abstract][Full Text] [Related]
8. Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas.
Ninatti G; Sollini M; Bono B; Gozzi N; Fedorov D; Antunovic L; Gelardi F; Navarria P; Politi LS; Pessina F; Chiti A
Neuro Oncol; 2022 Sep; 24(9):1546-1556. PubMed ID: 35171292
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin Receptors in an Anaplastic Oligodendroglioma Relapse Evidenced By 68Ga DOTANOC PET/CT.
Savelli G; Muni A
Clin Nucl Med; 2015 Jul; 40(7):e363-5. PubMed ID: 26018682
[TBL] [Abstract][Full Text] [Related]
10. Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography.
Iwadate Y; Shinozaki N; Matsutani T; Uchino Y; Saeki N
J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):1016-21. PubMed ID: 26848169
[TBL] [Abstract][Full Text] [Related]
11. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.
Derlon JM; Petit-Taboué MC; Chapon F; Beaudouin V; Noël MH; Creveuil C; Courtheoux P; Houtteville JP
Neurosurgery; 1997 Feb; 40(2):276-87; discussion 287-8. PubMed ID: 9007859
[TBL] [Abstract][Full Text] [Related]
12. Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
Shibahara I; Kumabe T; Kanamori M; Saito R; Sonoda Y; Watanabe M; Iwata R; Higano S; Takanami K; Takai Y; Tominaga T
J Neurosurg; 2010 Aug; 113(2):358-68. PubMed ID: 19895196
[TBL] [Abstract][Full Text] [Related]
13. B cell non-Hodgkin cerebral lymphoma associated with an anaplastic oligodendroglioma.
Fewings PE; Bhattacharyya D; Crooks D; Morris K
Clin Neuropathol; 2002; 21(6):243-7. PubMed ID: 12489671
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive grading of oligodendrogliomas: correlation between in vivo metabolic pattern and histopathology.
Derlon JM; Chapon F; Noël MH; Khouri S; Benali K; Petit-Taboué MC; Houtteville JP; Chajari MH; Bouvard G
Eur J Nucl Med; 2000 Jul; 27(7):778-87. PubMed ID: 10952489
[TBL] [Abstract][Full Text] [Related]
15. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours.
Cicuendez M; Lorenzo-Bosquet C; Cuberas-Borrós G; Martinez-Ricarte F; Cordero E; Martinez-Saez E; Castell-Conesa J; Sahuquillo J
Clin Neurol Neurosurg; 2015 Dec; 139():328-33. PubMed ID: 26588352
[TBL] [Abstract][Full Text] [Related]
16. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using f-18-fluorodeoxyglucose and c-11-L-methylmethionine.
Hölzer T
Neurosurgery; 1998 May; 42(5):1200-1. PubMed ID: 9588575
[No Abstract] [Full Text] [Related]
17. Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors.
Ericson K; Lilja A; Bergström M; Collins VP; Eriksson L; Ehrin E; von Holst H; Lundqvist H; Långsrom B B; Mosskin M
J Comput Assist Tomogr; 1985; 9(4):683-9. PubMed ID: 3926834
[TBL] [Abstract][Full Text] [Related]
18. Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas.
Nojiri T; Nariai T; Aoyagi M; Senda M; Ishii K; Ishiwata K; Ohno K
J Neurooncol; 2009 Jun; 93(2):233-41. PubMed ID: 19099197
[TBL] [Abstract][Full Text] [Related]
19. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
[TBL] [Abstract][Full Text] [Related]
20. Multimodal
Karlberg A; Berntsen EM; Johansen H; Myrthue M; Skjulsvik AJ; Reinertsen I; Esmaeili M; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L
World Neurosurg; 2017 Dec; 108():989.e1-989.e8. PubMed ID: 28844925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
